GlassScriptPhysician profile
James M Mccullough
NPI 1104803766
$4,560.64
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $510 · 2021: $1,014 · 2022: $807 · 2023: $1,306 · 2024: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,045.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,370.60 | 2019-2024 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $1,123.65 | 2019-2024 | Tezspire, Fasenra, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $354.48 | 2019-2024 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $265.84 | 2019-2024 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $257.38 | 2021-2024 | Dupixent |
| Genzyme Corporation | $250.71 | 2020-2024 | |
| Grifols USA, LLC | $227.74 | 2020-2024 | Prolastin-C Liquid |
| Amgen INC. | $144.55 | 2021-2024 | Tezspire |
| Mylan Specialty L.P. | $129.65 | 2021-2024 | Yupelri |
| United Therapeutics Corporation | $94.91 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.94 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $57.70 | 2023-2024 | Winrevair |
| Nabriva Therapeutics, Plc | $40.06 | 2021-2022 | |
| Inogen, INC. | $34.73 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Circassia INC. | $26.59 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $23.56 | 2019 | |
| Baxter Healthcare | $22.08 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.43 | 2024 | Eliquis |
| Paratek Pharmaceuticals, INC. | $16.50 | 2021 | |
| Insmed, INC. | $15.02 | 2024 | Arikayce |
| Philips North America LLC | $13.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mccullough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.